Form D · Biotechnology
Nobell Foods, Inc.
South San Francisco, CA · CIK 0001876059
Offering snapshot reported Aug 20, 2021 · SEC filing
- Reported sold
- $27.4M Offering amount: $27.4M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 13, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 20, 2021 | Initial | $27,416,878 | No comparison | 20 | SEC filing |
| Aug 11, 2021 | Initial | $74,999,961 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-410652
Source: Form D, filed Aug 20, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Magi El Richani | Director, Executive |
| Vijay Pande | Director |
| Chris Rivest | Director |
| Kyle Vogt | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6000 Shoreline Court
South San Francisco, CA, 94080
South San Francisco, CA, 94080